IP Library Granted Patent US 9,134,324
Granted Patent B2
US 9,134,324 · App. 13/888,438 · Granted Sep 15, 2015

Patent

Inventors: Denise P. Dimitrov (Milltown, NJ); John G. Hoey (Farmingham, MA)
Assignee: Medical Diagnostic Laboratories, LLC
G01N33/6893G01N33/56911G01N2469/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,134,324
App. No.
13/888,438
Granted
Sep 15, 2015
Kind
B2
Abstract

Disclosed is the use of isolated Ats-1 protein in Anaplasma phagocytophilum in the ELISA detection of Anaplasma pathogen. The recombinant expression of Ats-1 and its use as a kit for ELISA are also disclosed.

Claims (18)

1. An ELISA kit for the diagnosis of Anaplasma phagocytophilum infection in a human patient, comprising:

a) an isolated recombinant Anaplasma translocated substrate-1 (Ats-1) protein antigen, said isolated recombinant Ats-1 protein antigen having the amino acid sequence of SEQ ID NO: 2, wherein said isolated recombinant Ats-1 protein antigen is immobilized onto the surface of a support made of a material selected from the group consisting of polyethylene, polypropylene and glass;

b) a detection antibody, said detection antibody is an anti-human IgG or anti-human IgM antibody, and said detection antibody is conjugated with a label selected from the group consisting of a fluorophore, radioactive label and enzyme,

wherein

said immobilized isolated recombinant Ats-1 protein antigen binds to an anti-Ats-1 antibody that is present in a biological sample of a human patient suspected of having an infection of Anaplasma phagocytophilium to form a complex of antigen-antibody and detection of the formation of said antigen-antibody complex by said detection antibody is indicative of Anaplasma phagocytophilium infection in said human patient.

2. The ELISA kit of claim 1 , wherein said anti-Ats-1 antibody is an IgG antibody.

3. The ELISA kit of claim 1 , wherein said anti-Ats-1 antibody is an IgM antibody.

4. The ELISA kit of claim 2 , wherein said ELISA kit has a sensitivity of at least 90% and specification of at least 80%.

5. The ELISA kit of claim 3 , wherein said ELISA kit has a sensitivity of at least 90% and specificity of at least 75%.

6. The ELISA kit of claim 1 , wherein said support is made of polypropylene.

7. The ELISA kit of claim 1 , wherein said support is a microtiter well.

8. The ELISA kit of claim 1 , further comprising:

(c) a detection reagent, said detection reagent is an enzyme substrate.

9. The ELISA kit of claim 1 , wherein said fluorophore is fluorescein or rhodamine.

10. The ELISA kit of claim 8 , further comprising:

(d) an instruction, said instruction providing a procedure for detecting the presence of said anti-Ats-1 antibody in a biological sample obtained from a human patient.

11. The ELISA kit of claim 1 , wherein said radioactive label is selected from the group consisting of radioisotope 32 P, 14 C, 125 I, 3 H and 131 I.

12. The ELISA kit of claim 1 , wherein said enzyme is selected from the group consisting of horseradish peroxidase, alkaline phosphatase and glucose oxidase.

Assignments (4)
SECURITY INTEREST Recorded Jul 13, 2022
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 060638/0353 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
SECURITY INTEREST Recorded Apr 27, 2018
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 046031/0381 →
SECURITY INTEREST Recorded Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
Continuity (3)
Division 13134980 · Jun 22, 2011
Provisional Application 61399639 · Jul 15, 2010
Related Publication 20130295656A1 · Nov 7, 2013